ELV - Elevance Health, Inc.
After hours:
| Previous Close | 450.08 |
| Open | 449.11 |
| Bid | 440.09 x 1100 |
| Ask | 455.74 x 900 |
| Day's Range | 445.45 - 454.20 |
| 52 Week Range | 440.02 - 549.52 |
| Volume | |
| Avg. Volume | 1,086,485 |
| Market Cap | 105.701B |
| Beta (5Y Monthly) | 0.85 |
| PE Ratio (TTM) | 17.30 |
| EPS (TTM) | 25.77 |
| Earnings Date | Jul 18, 2023 - Jul 24, 2023 |
| Forward Dividend & Yield | 5.92 (1.33%) |
| Ex-Dividend Date | Jun 08, 2023 |
| 1y Target Est | 573.45 |
ZacksHere's Why You Should Hold Elevance (ELV) in Your Portfolio
Improving top line, investments in high-growth businesses, membership hikes and significant new contracts in its government business poise Elevance Health (ELV) well for growth.
ZacksWhy Is Elevance Health (ELV) Up 0% Since Last Earnings Report?
Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Business Wire
Elevance Health Announces Appearance at the Bernstein 39th Annual Strategic Decisions Conference
INDIANAPOLIS, May 18, 2023--Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the Bernstein 39th Annual Strategic Decisions Conference in New York City on June 1, at 8:00 a.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the "Investors" link. You may also access the webcast by clicking on the following link https://kvgo.com/bernstein-2023
ZacksAre You a Value Investor? This 1 Stock Could Be the Perfect Pick
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Motley Fool2 Top Healthcare Stocks to Buy Right Now
Higher interest rates and plunging growth forecasts have been the economic fallout from inflation that has been elevated throughout some of 2021, all of 2022, and all this year so far. Given the essential nature of the goods and services provided by the healthcare sector, it is arguably one of the more durable economic sectors. Pfizer (NYSE: PFE) is probably best known today for its COVID-19 vaccine, Comirnaty, which it co-owns with BioNTech, and the COVID-19 antiviral treatment Paxlovid.
- Business Wire
Elevance Health Announces Appearance at the 2023 RBC Capital Markets Global Healthcare Conference
INDIANAPOLIS, May 05, 2023--Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the 2023 RBC Capital Markets Global Healthcare Conference in New York City on May 17, at 8:00 a.m. Eastern Standard Time (EST). All interested parties are invited to listen to a webcast of the presentation by visiting www.elevancehealth.com and selecting the "Investors" link. Following the presentation, a webcast replay will be available for 90 days.
ZacksCigna (CI) Q1 Earnings Surpass Estimates, Ups '23 EPS View
Cigna's (CI) first-quarter 2023 results indicate a strong contribution to revenues from Evernorth Health Services and Cigna Healthcare businesses. Management currently expects adjusted EPS to be a minimum of $24.70 in 2023.
ZacksAcadia Healthcare (ACHC) Q1 Earnings Beat on Higher Patient Volumes
Acadia Healthcare's (ACHC) Q1 results reflect higher revenue per patient day, partly offset by an elevated cost level. Management reaffirms its 2023 business guidance.
ZacksTeladoc Health (TDOC) Shares Up 5% Since Q1 Earnings Release
Teladoc Health's (TDOC) Q1 results reflect solid chronic care product revenues and improving access fees and other revenues.
ZacksELV vs. AMEH: Which Stock Is the Better Value Option?
ELV vs. AMEH: Which Stock Is the Better Value Option?
ZacksAMN Healthcare (AMN) to Post Q1 Earnings: What's in the Cards?
AMN Healthcare's (AMN) first-quarter results are likely to reflect soft demand across its segments.
ZacksUniversal Health (UHS) Q1 Earnings Beat on Higher Admissions
Universal Health's (UHS) Q1 results reflect strong performance in acute care and behavioral health segments. Meanwhile, the elevated expense level partially offsets the positives.
ZacksHumana (HUM) Q1 Earnings Beat on Growing Membership & Premiums
Humana (HUM) expects adjusted EPS to be at least $28.25 in 2023, up from the previous guidance of $28 per share.
ZacksCentene (CNC) Q1 Earnings Miss Estimates, '23 EPS View Raised
Centene's (CNC) first-quarter 2023 results grapple with higher operating expenses, partly offset by an expanding customer base. Management presently expects adjusted EPS to be at least $6.40 in 2023.
Motley FoolShould Dividend Growth Investors Buy This Blue Chip Healthcare Stock?
While the stock market tends to appropriately value stocks over the long run, this is far from always the case in the short term. The element of human emotion can often send stocks soaring or plunging beyond anything that their fundamentals would justify.
ZacksElevance Health (ELV) is an Incredible Growth Stock: 3 Reasons Why
Elevance Health (ELV) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Simply Wall St.Elevance Health's (NYSE:ELV) Upcoming Dividend Will Be Larger Than Last Year's
Elevance Health, Inc. ( NYSE:ELV ) has announced that it will be increasing its dividend from last year's comparable...
ZacksHCA Healthcare (HCA) Beats on Q1 Earnings, Ups '23 EPS View
HCA Healthcare's (HCA) first-quarter results gain from increased patient admissions. Management expects EPS within the $17.25-$18.55 band this year, higher than the previous view of $16.40-$17.60.
- Thomson Reuters StreetEvents
Q1 2023 Elevance Health Inc Earnings Call
Q1 2023 Elevance Health Inc Earnings Call
ZacksElevance Health (ELV) Beats on Q1 Earnings, Hikes Profit View
Elevance Health's (ELV) first-quarter results reflect growing premiums stemming from rate increases.
ZacksElevance Health (ELV) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Elevance Health (ELV) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- Zacks
Elevance Health (ELV) Tops Q1 Earnings and Revenue Estimates
Elevance Health (ELV) delivered earnings and revenue surprises of 2.16% and 2.48%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
Elevance Health Reports First Quarter 2023 Results
INDIANAPOLIS, April 19, 2023--Elevance Health, Inc. (NYSE: ELV) reported first quarter 2023 results reflecting strong financial performance, including double-digit growth in revenue, operating earnings, and adjusted earnings per share.
ZacksELV or DOCS: Which Is the Better Value Stock Right Now?
ELV vs. DOCS: Which Stock Is the Better Value Option?
ZacksElevance Health (ELV) to Post Q1 Earnings: What's in Store?
Elevance Health's (ELV) first-quarter results are likely to reflect higher premiums, commercial and government sales figures and total expenses.